3,276
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Chemotherapy-Induced Neutropenia/Febrile Neutropenia Prophylaxis with Biosimilar Filgrastim in Solid Tumors Versus Hematological Malignancies: MONITOR-GCSF Study

, , , , , , , & show all
Pages 897-907 | Received 22 Oct 2018, Accepted 05 Dec 2018, Published online: 04 Mar 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Matias F Martinez, Enzo Alveal, Tomas G Soto, Eva I Bustamante, Fernanda Ávila, Shrikant I Bangdiwala, Ivonne Flores, Claudia Benavides, Ricardo Morales, Nelson M Varela & Luis A Quiñones. (2020) IL-6 −572C>G and CARD8 304T>A Genetic Polymorphisms are Associated with the Absolute Neutrophil Count in Patients with Hematological Malignancies Under Chemotherapy: An Application of Multilevel Models to a Preliminary Pharmacogenetic Study. Pharmacogenomics and Personalized Medicine 13, pages 337-343.
Read now

Articles from other publishers (7)

Jean-Marc Phelip, Pierre-Jean Souquet, Maya Hacini, Mohamad Chehimi, Vincent Bourgeois, Ryma Bennoune & Olivier Tredan. (2023) G-CSF filgrastim biosimilar-Sandoz reduces the incidence of febrile neutropenia in patients receiving chemotherapy regimens with rest periods not exceeding 14 days: A French, multicenter, prospective, non-interventional study. Cancer Treatment and Research Communications 35, pages 100690.
Crossref
Deeksha Joshi, Rubiya Khursheed, Saurabh Gupta, Diksha Wadhwa, Thakur Gurjeet Singh, Sumit Sharma, Sejal Porwal, Swati Gauniyal, Sukriti Vishwas, Sanjay Goyal, Gaurav Gupta, Rajaraman D. Eri, Kylie A. Williams, Kamal Dua & Sachin Kumar Singh. (2022) Biosimilars in Oncology: Latest Trends and Regulatory Status. Pharmaceutics 14:12, pages 2721.
Crossref
Rinda Devi Bachu, Mariam Abou‐Dahech, Swapnaa Balaji, Sai H. S. Boddu, Samson Amos, Vishal Singh, R. Jayachandra Babu & Amit K. Tiwari. (2022) Oncology biosimilars: New developments and future directions. Cancer Reports 5:11.
Crossref
Wei Tian, Yali Wang, Yunxiang Zhou, Yihan Yao & Yongchuan Deng. (2022) Effects of Prophylactic Administration of Granulocyte Colony-Stimulating Factor on Peripheral Leukocyte and Neutrophil Counts Levels After Chemotherapy in Patients With Early-Stage Breast Cancer: A Retrospective Cohort Study. Frontiers in Oncology 12.
Crossref
Aayushi S. Ditani, Pragyan Paramita Mallick, Neelima Anup, Vishakha Tambe, Suryanarayana Polaka, Pinaki Sengupta, Kuldeep Rajpoot & Rakesh K. Tekade. (2021) Biosimilars accessible in the market for the treatment of cancer. Journal of Controlled Release 336, pages 112-129.
Crossref
Massimo Martino, Mercedes Gori, Giovanni Tripepi, Anna Grazia Recchia, Michele Cimminiello, Pasquale Fabio Provenzano, Virginia Naso, Anna Ferreri, Tiziana Moscato, Giuseppe Console, Barbara Loteta, Giuseppe Alberto Gallo, Massimo Gentile, Vanessa Innao, Marco Rossi, Antonella Morabito, Iolanda Donatella Vincelli, Donato Mannina & Annalisa Pitino. (2019) A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant. Annals of Hematology 99:2, pages 331-341.
Crossref
Sofia Konstantinidou, Angeliki Papaspiliou & Eleni Kokkotou. (2019) Current and future roles of biosimilars in oncology practice (Review). Oncology Letters.
Crossref